Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
äŒæ¥ã³ãŒãLFCR
äŒç€ŸåLifecore Biomedical Inc
äžå Žæ¥Feb 15, 1996
æé«çµå¶è²¬ä»»è
ãCEOãJosephs (Paul)
åŸæ¥å¡æ°406
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Feb 15
æ¬ç€Ÿæåšå°3515 Lyman Boulevard
éœåžCHASKA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·55318
é»è©±çªå·19523684300
ãŠã§ããµã€ãhttps://www.lifecore.com/
äŒæ¥ã³ãŒãLFCR
äžå Žæ¥Feb 15, 1996
æé«çµå¶è²¬ä»»è
ãCEOãJosephs (Paul)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã